Michele Boldini
Papers
4
Total Citations
27
H-Index
3
About
Michele Boldini is a rising urologic surgeon and researcher whose work centers on optimizing surgical outcomes in robotic-assisted procedures for kidney and prostate cancers. His primary research areas include minimally invasive oncology, postoperative recovery, and surgical volume-outcome relationships. Boldini’s major contributions involve patient-centered comparisons of surgical approaches, such as his propensity-score matched study on transperitoneal versus retroperitoneal robotic partial nephrectomy (14 citations), which provided crucial data on mobilization, bowel function, and pain management. He also demonstrated that high-volume surgeons significantly reduce operating time in robot-assisted radical prostatectomy (6 citations), a finding with direct implications for surgical training and resource allocation. His work on omitting abdominal drains after partial nephrectomy (5 citations) challenges routine practices to enhance recovery. Additionally, Boldini validated the 2012 Briganti nomogram as a predictor of disease progression in high-risk prostate cancer patients (2 citations), bridging risk stratification with surgical decision-making. With over 27 citations across his most-cited papers, all published in 2024, Boldini is establishing himself as a thoughtful investigator dedicated to refining surgical techniques and improving patient quality of life through evidence-based, recovery-focused innovations.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4